Pyrimidinedione derivative compounds, method of producing the same and antiarrythmic agents containing the same
CA 2001389 C · Owner: Sannohe, Kunio · Inventors: Ishii, Masaaki; Kawauchi, Nobuya; Kamiya, Joji
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compounds of formula (1) are provided which are useful as Class III type antiarrythmic agents improving cardiac dysfunction, cardiac insufficiency and provide positive inotropic action. The compounds of this invention are embodied by formula (1). (see fig.I) in which A represents -(CH2)m-, -B-(CH2)k- -D-(CH2)1-, (see fig.II) or (see fig.III); B represents an oxygen or a sulfur atom (see fig.IV), (see fig V), or (see fig. VI); D represents (see fig.VII), (see fig. VIII) or (see fig.IX); R1 and R2 each independently represent a hydrogen atom a, lower alkyloxycarbonyl group, an unsaturated lower alkyl group or a lower alkyl group, any one of the hydrogen atoms of said alkyl groups may be …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 24, 1989 and granted February 10, 1998. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended October 24, 2009.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 24, 2011.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.